Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07230470

Comparative Study of LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation.

Led by Universidad Pontificia de Salamanca · Updated on 2026-05-04

40

Participants Needed

1

Research Sites

27 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The use of robotic technology for the treatment of gait in neurological pathologies has provided different results in scientific evidence. In patients with some types of acquired brain damage, such as stroke, the use of Lokomat® therapy can bring improvements in aspects such as gait speed and balance, among other parameters and report greater functional recovery in subacute patients with greater deterioration. Similarly, the use of another technological element such as the C-Mill® reports improvements in various aspects of ambulation and balance in gait treatments for stroke patients. Likewise, the impact on the person's recovery is not only beneficial for gait rehabilitation, but also improves the perception of well-being, which can be positive in the process of readaptation to daily life. The effect of both treatments for gait rehabilitation in adults with stroke and their impact on quality of life in the neurorehabilitation clinic will be studied. adults with stroke and their impact on quality of life at the Lescer neurorehabilitation clinic Lescer, Madrid (Spain). Participants will be assessed at baseline, 4 weeks, 8 weeks and 12 weeks.

CONDITIONS

Official Title

Comparative Study of LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation.

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of stroke (haemorrhagic and/or ischaemic) by a specialist physician.
  • Adults aged 18 to 65 years.
  • Cognitively capable subjects who can sign the informed consent form.
Not Eligible

You will not qualify if you...

  • Severe cognitive impairment (Mini-Mental State Examination < 24) or inability to understand treatment instructions.
  • Diagnosis of other neurological diseases or craniocerebral trauma.
  • Other diseases interfering with gait such as disabling arthritis or osteoarthritis.
  • Contraindications for use of the robotic tools used in the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Universidad Pontificia de Salamanca

Salamanca, Spain, 37002

Actively Recruiting

Loading map...

Research Team

J

Jorge V Velázquez Saornil, PhD.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here